DENTSPLY SIRONA (XRAY) director Brian Gladden buys 9,985.022 shares at $10.015

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Brian T. Gladden reported an open-market purchase of 9,985.022 shares of common stock on June 15, 2026. The weighted average purchase price was $10.015 per share, based on multiple trades between $10.015 and $10.0156. Following this transaction, he directly owns 61,848.544 shares of the company’s common stock.

Insider Trade Summary

Net Buyer: 9,985.022 shares ($100,000)

Net Buy 1 txn

Insider Gladden Brian T

Role null

Bought 9,985.022 shs ($100K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	9,985.022	$10.015	$100K

Holdings After Transaction: Common Stock — 61,848.544 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares purchased: 9,985.022 shares Weighted average price: $10.015 per share Post-transaction holdings: 61,848.544 shares +1 more

4 metrics

Shares purchased 9,985.022 shares Open-market purchase on June 15, 2026

Weighted average price $10.015 per share Price for 9,985.022 purchased shares

Post-transaction holdings 61,848.544 shares Common stock directly owned after transaction

Trade price range $10.015 to $10.0156 Range of prices for individual purchase trades

Key Terms

open-market purchase, weighted average price, Common Stock

3 terms

open-market purchase financial

"transaction_action: "open-market purchase" for the common stock buy"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Common Stock financial

"security_title: "Common Stock" for the reported transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gladden Brian T

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NORTH CAROLINA 28277

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/15/2026		P		9,985.022	A	$10.015(1)	61,848.544	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.015 to 10.0156, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Brian T. Gladden	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) disclose for Brian T. Gladden?

DENTSPLY SIRONA (XRAY) disclosed that director Brian T. Gladden bought 9,985.022 shares of common stock in an open-market purchase. The transaction increased his direct holdings to 61,848.544 shares, signaling a larger personal stake in the company.

At what price did Brian T. Gladden buy DENTSPLY SIRONA (XRAY) shares?

Brian T. Gladden purchased DENTSPLY SIRONA (XRAY) common shares at a weighted average price of $10.015 per share. The filing notes that trades occurred in multiple transactions, with prices ranging from $10.015 to $10.0156 inclusive during the purchase.

How many DENTSPLY SIRONA (XRAY) shares does Brian T. Gladden own after this Form 4?

After the reported transaction, Brian T. Gladden directly owns 61,848.544 shares of DENTSPLY SIRONA (XRAY) common stock. This total reflects his position immediately following the 9,985.022-share open-market purchase disclosed in the Form 4 filing.

Was Brian T. Gladden’s DENTSPLY SIRONA (XRAY) transaction a purchase or a sale?

The Form 4 shows that Brian T. Gladden executed a purchase of DENTSPLY SIRONA (XRAY) common stock. The transaction code is “P,” indicating an open-market or private transaction buy, with no reported share sales in this particular filing.

Did the DENTSPLY SIRONA (XRAY) insider trade involve derivatives or only common stock?

The disclosed DENTSPLY SIRONA (XRAY) insider transaction involved only common stock. The filing lists one non-derivative transaction for 9,985.022 shares, and the derivative summary shows no options, warrants, or other derivative instruments reported in this Form 4.